Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

(2018) Andrea Cipriani et al.   LANCET

Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – A Danish nationwide study

(2018) Brian Villumsen Broberg et al.   SCHIZOPHRENIA RESEARCH

Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial

(2017) Muhammad I Husain et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial

(2017) Dennis Chan et al.   LANCET NEUROLOGY

Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial

(2017) Maryam Alamdarsaravi et al.   PSYCHIATRY RESEARCH

Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies

(2017) Christopher E.M. Griffiths et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study

(2016) Ole Köhler et al.   AMERICAN JOURNAL OF PSYCHIATRY

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment

(2016) Ole Kohler et al.   Current Neuropharmacology

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients

(2016) Hamid Emadi-Kouchak et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A randomised, double-blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia

(2016) H. Mahagna et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials

(2016) Estela Salagre et al.   JOURNAL OF AFFECTIVE DISORDERS

Interpretation of the evidence for the efficacy and safety of statin therapy

(2016) Rory Collins et al.   LANCET

Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions

(2016) N Kappelmann et al.   MOLECULAR PSYCHIATRY

Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report

(2016) Sriram Yennurajalingam et al.   ONCOLOGIST

Inflammation and Specific Symptoms of Depression

(2016) Markus Jokela et al.   JAMA Psychiatry

Telomere length as a predictor of response to Pioglitazone in patients with unremitted depression: a preliminary study

(2016) N Rasgon et al.   Translational Psychiatry

Inflammation and clinical response to treatment in depression: A meta-analysis

(2015) R. Strawbridge et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial

(2015) S. Jafari et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial

(2015) Amirhossein Gougol et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response

(2015) Kathleen Watson Lin et al.   PSYCHIATRY RESEARCH

An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline

(2014) Rudolf Uher et al.   AMERICAN JOURNAL OF PSYCHIATRY

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder

(2014) Mohammad Haghighi et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects

(2014) Ole Köhler et al.   JAMA Psychiatry

NSAIDs Are Associated with Lower Depression Scores in Patients with Osteoarthritis

(2013) Rupa L. Iyengar et al.   AMERICAN JOURNAL OF MEDICINE

Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor-  Inhibitors: Systematic Review of the Literature

(2013) S. S. Toussi et al.   CLINICAL INFECTIOUS DISEASES

AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL

(2013) Ahmad Ghanizadeh et al.   DEPRESSION AND ANXIETY

Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders

(2013) Michael E. Benros et al.   JAMA Psychiatry

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study

(2012) Seyed-Hesameddin Abbasi et al.   JOURNAL OF AFFECTIVE DISORDERS

Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial

(2012) Khatereh Sepanjnia et al.   NEUROPSYCHOPHARMACOLOGY

Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study

(2012) Tsuyoshi Miyaoka et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

(2012) Charles L. Raison et al.   JAMA Psychiatry

Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial

(2011) Cynthia Fields et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept

(2011) S. Tyring et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

TNF-α Antagonist Infliximab in the Treatment of Depression in Older Adults

(2010) D. Willemijn Maas et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

(2010) Richard G. Langley et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial

(2010) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial

(2009) J Kekow et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

(2009) Shahin Akhondzadeh et al.   DEPRESSION AND ANXIETY

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

(2009) M Bryant Howren et al.   PSYCHOSOMATIC MEDICINE

Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial

(2008) Edward V. Loftus et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY